Axel Pagenstecher

5PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 12, 2024
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.

Kai Zhao, Madita Braun, Leonie Meyer

|Dec 23, 2023
Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice.

Kai Zhao, Pilar Calero-Pérez, Miriam H A Bopp

|Jan 11, 2022
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells.

Kai Zhao, Agnes Schäfer, Zhuo Zhang

|Sep 30, 2021
Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche.

Anna Hupfer, Anna Brichkina, Anke Koeniger

|Jul 03, 2019
Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor.

Ricarda Hannen, Martin Selmansberger, Maria Hauswald

Pageof 1

Frequent Collaborators

4 joint publications

Christopher Nimsky

4 joint publications

Jörg Walter Bartsch

2 joint publications

Kai Zhao

2 joint publications

Tillmann Rusch